Aecon announces next quarterly dividend GlobeNewswire December 15, 2025 TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that the Board of Directors approved its next quarterly dividend of 19 cents per share. The dividend will be paid on January 5, 2026 to shareholders of record as of December […]
Sportradar Shareholders Elect Breon Corcoran, CEO of IG Group, to Board of Directors Globally renowned executive in betting, gaming, and fintech boasts track record of driving innovation, digital transformation, and international growth GlobeNewswire December 15, 2025 ST. GALLEN, Switzerland, Dec. 15, 2025 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD), a leading global sports technology
3D Systems Announces FDA 510(k) Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents Removes Key Adoption Barriers in Pediatric/Adolescent Oncology and Deformity Market GlobeNewswire December 15, 2025 ROCK HILL, S.C., Dec. 15, 2025 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced that the U.S. Food and Drug Administration has granted 510(k) clearance
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://stockdropcenter.com/moonlake-lawsuit-submission-form?prid=180342&wire=1&utm_campaign=12 or call (212) 363-7500 to speak to our team of experienced shareholder
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://stockdropcenter.com/synopsys,-inc.-lawsuit-submission-form?prid=180341&wire=1&utm_campaign=3 or call (212) 363-7500 to speak to our team of experienced shareholder
Cencora, Inc. today announced it has entered into a definitive agreement to acquire TPG's equity interest in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology. The transaction marks an important step for OneOncology and its practice partners, following significant physician-led investment and growth for the platform. https://mma.prnewswire.com/media/2845492/OO_Cencora_TPG_Social.jpg “We are pleased
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ:AGIO) concerning possible violations of federal securities laws. On November 19, 2025, Agios reported topline results from its RISE UP Phase 3 trial of Mitapivat in
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://investorclaimform.com/dexcom-lawsuit-submission-form?prid=180339&wire=1&utm_campaign=19 or call (212) 363-7500 to speak to our team of experienced shareholder
Los Angeles, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Claire's Place Foundation, a nonprofit organization providing support to children and families affected by cystic fibrosis (CF), closes out an impactful year marked by emergency action, creative community fundraising and expanded programs to continue to meet the evolving needs of individuals with CF. A Year of
Claire's Place Foundation Steps Up for Cystic Fibrosis Community in a Year Marked by Wildfires & Rising Costs As financial pressures on the cystic fibrosis community intensify, Claire's Place delivers rapid relief, creative fundraising & new long-term funding tools GlobeNewswire December 15, 2025 Los Angeles, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Claire's Place Foundation,